Pharma Mar | PHM - Operating Profit


Pharma Mar reported EUR7.65M in Operating Profit for its fiscal quarter ending in September of 2026.





Operating Profit Change Date
Akebia Therapeutics USD -5.45M 9.4M Dec/2025
Alaunos Therapeutics USD -952K 60K Jun/2026
Almirall EUR 71.55M 41.32M Jun/2026
Avita Medical AUD -6.86M 3.55M Jun/2026
Dianthus Therapeutics USD -61.48M 14.95M Jun/2026
Ionis Pharmaceuticals USD -102.29M 15.71M Jun/2026
IQVIA Holdings USD 608M 1.99B Sep/2026
Laboratorios Farma EUR 135.05M 49.84M Dec/2023
Moderna USD -815M 573M Jun/2026
Organon & Co USD 377M 54M Sep/2026
Pharma Mar EUR 7.65M 9.06M Sep/2026
Revvity USD 126.14M 43.36M Jun/2026
Tectonic Therapeutic USD -24.22M 3.08M Jun/2026
Viatris USD 73.7M 93.9M Jun/2026
Xeris Pharmaceuticals USD 5.17M 2.74M Jun/2026